Biocon Limited announced significant management changes following its Board meeting on March 27, 2026, effective April 01, 2026. The Board accepted the resignations of Mr. Siddharth Mittal (CEO & MD) and Mr. Mukesh Kamath (Interim CFO), both transitioning to new roles within the Biocon Group. Concurrently, Mr. Shreehas Pradeep Tambe was appointed as the new CEO & MD, and Mr. Kedar Narayan Upadhye as the new CFO, subject to shareholder approval.
Biocon Announces Strategic Management Transitions
Biocon Limited has approved several changes to its key executive roles and Senior Management Personnel structure, effective from April 01, 2026. These changes follow the strategic goal of creating a unified global biopharmaceutical leader, as previously announced in December 2025.
Change in CEO and Managing Director
The Board accepted the resignation of Mr. Siddharth Mittal from the position of Chief Executive Officer and Managing Director, effective the close of business hours on March 31, 2026, to take up another leadership role within the Biocon Group.
Based on the Nomination and Remuneration Committee’s recommendation, the Board approved the appointment of Mr. Shreehas Pradeep Tambe, currently CEO & MD of Biocon Biologics Limited (BBL), as an Additional Director effective April 01, 2026. He is further appointed as the new Chief Executive Officer and Managing Director for a period of five years, effective April 01, 2026, subject to necessary shareholder approvals.
Change in Chief Financial Officer
The resignation of Mr. Mukesh Kamath as Interim Chief Financial Officer was accepted, effective March 31, 2026, as he moves to a new role within the Group.
The Board approved the appointment of Mr. Kedar Narayan Upadhye, CFO of BBL, as the Chief Financial Officer of the Company, effective April 01, 2026.
Appointment of New Key Managerial Personnel (KMP)
The Board designated Mr. Akhilesh Nand, Company Secretary of BBL, as the Head, Governance, Risk and Compliance of the Company, effective April 01, 2026, and appointed him as a Key Managerial Personnel.
Changes in Senior Management Personnel
New designations approved effective April 01, 2026:
- Mr. Naveen Narayanan (Head, Global Head of HR of BBL) designated as Chief Human Resources Officer.
- Mr. Mandar Shrikant Ghatnekar (Global Head of IT & Digital Transformation of BBL) designated as Chief Technology Officer.
The following individuals ceased to be Senior Management Personnel effective the close of business hours of March 31, 2026:
- Mr. Abhijit Zutshi (Chief Commercial Officer)
- Mr. Manoj Kumar Pananchukunnath (Chief Scientific Officer)
- Mr. Arun Kumar Gupta (Chief Operating Officer)
- Mr. Maninder Kapoor Puri (Head, Human Resources)
- Mr. Nitin Tiwari (Head, Quality)
- Mr. Vishal Nayyar (Head, Supply Chain Management)
- Mr. Amit Kaptain (Head, Commercials, API)
Authorized Key Managerial Personnel for Disclosure
The Board severally authorized the following Key Managerial Personnel (KMP) for determining materiality and making disclosures, effective April 01, 2026:
| Name | Designation |
|---|---|
| Ms. Kiran Mazumdar-Shaw | Executive Chairperson |
| Mr. Shreehas Pradeep Tambe | Chief Executive Officer and Managing Director |
| Mr. Kedar Narayan Upadhye | Chief Financial Officer |
| Mr. Akhilesh Nand | Head, Governance, Risk and Compliance |
| Mr. Rajesh Umakant Shanoy | Company Secretary |
The Board meeting commenced at 10:50 A.M. and concluded at 11:35 A.M. on March 27, 2026.
Source: BSE
